AIMLogo.jpg
Low Natural Killer (NK) Activity Observed Across the Chronic Fatigue Syndrome (CFS) Disease Spectrum
12 janv. 2015 08h30 HE | AIM ImmunoTech Inc.
PHILADELPHIA, Jan. 12, 2015 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), reported today that it has conducted new in vitro studies of natural killer...
AIMLogo.jpg
Ampligen(R) Blocks Critical Ebola Viral Disease (EVD) Protein Which is Linked to High Mortality in Man
17 nov. 2014 09h08 HE | AIM ImmunoTech Inc.
PHILADELPHIA, Nov. 17, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), announced today that it had received a new research report from Professor...
AIMLogo.jpg
Hemispherx Biopharma and United States Army Medical Research Institute of Infectious Diseases (USAMRIID) Collaborate on Alferon(R) and Ampligen(R) Against the Ebola Virus
03 nov. 2014 08h30 HE | AIM ImmunoTech Inc.
PHILADELPHIA, Nov. 3, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), has been informed by USAMRIID scientists that they have in-vitro data...
AIMLogo.jpg
Hemispherx Announces Strategic Relationship With Squire Patton Boggs, Washington, DC as Governmental Counsel in Fight Against Ebola
20 oct. 2014 12h00 HE | AIM ImmunoTech Inc.
PHILADELPHIA, Oct. 20, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), has retained Squire Patton Boggs (SPB) to serve as its global government...
AIMLogo.jpg
Hemispherx's Two Drugs, Ampligen(R) and Alferon(R) Ranked Highly in Sensitivity Testing Against MERS/SARS Coronaviruses
04 août 2014 08h30 HE | AIM ImmunoTech Inc.
PHILADELPHIA, Aug. 4, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE MKT:HEB) announced today a peer-reviewed electronic publication entitled "Sensitivity of SARS/MERS CoV to Interferons and...
RoseComm_logo.jpg
Father Martin's Ashley's Pain Recovery Program Head Comments in Baltimore Magazine Article on Prescription Drug Addiction in the Suburbs
21 juil. 2014 11h37 HE | Father Martin's Ashley
HAVRE DE GRACE, MD--(Marketwired - Jul 21, 2014) - -- Father Martin's Ashley Carol Bowman, M.D., staff physician and director of Ashley's Pain Recovery Program,...
National Women's Health Week
06 mai 2014 12h04 HE | U.S. Food and Drug Administration
Silver Spring, MD, May 6, 2014 (GLOBE NEWSWIRE) -- May 11 -17, 2014 is National Women's Health Week. Throughout the week, the U.S. Food and Drug Administration (FDA) Office of Women's Health is...
DEA Drug Take-Back Collection Site Locator Now Available
23 avr. 2014 09h30 HE | National Association of Boards of Pharmacy
MOUNT PROSPECT, IL--(Marketwired - Apr 23, 2014) - 1.3 million emergency department visits in 2010 were related to prescription drug misuse or abuse. Approximately 50 percent of teens believe...
C3 Jian Initiates Ph
C3 Jian Initiates Phase 2 Clinical Trial of Anti-Cavity Drug
07 mars 2014 18h40 HE | C3 Jian, Inc.
LOS ANGELES, March 7, 2014 (GLOBE NEWSWIRE) -- C3 Jian, Inc., a private company focused on providing improved oral healthcare, announced today that the first Phase 2 Clinical Trial for its novel drug,...
AIMLogo.jpg
Hemispherx Analysis of New Data on Protection From Pulmonary Damage Associated With Infection by Highly Pathogenic Influenza Virus
22 janv. 2014 08h30 HE | AIM ImmunoTech Inc.
PHILADELPHIA, Jan. 22, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE MKT:HEB), today announced that Dr. William M. Mitchell of Vanderbilt University presented a research paper on January 21,...